Anberber Sissay, Tessema Tesfaye, Yimer Awol
Department of pediatrics, Gondar College of medical sciences, Gondar, Ethiopia.
Ethiop Med J. 2003 Oct;41(4):301-10.
A prospective hospital based study on severe malaria in under-five children was carried out over a period of one year in a district hospital of Ethiopia to determine the case fatality rate (CFR), factors contributing for high mortality, health seeking behaviour of the care takers, direct cost and feasibility of operating the WHO treatment guidelines at a district level. One hundred and one children aged between 6 and 59 months fulfilling the criteria of severe malaria have been recruited in the study and treated according to WHO guidelines. The most frequently encountered clinical manifestations of severe malaria were prostration and hypoglycaemia, the prevalence being 28.7% respectively. The over all case fatality rate of severe malaria was 11.9%. Cerebral malaria was the only isolated form of severe malaria with high CFR (OR=5.06, 95%CI 1.01-25.1). The hospital CFR of severe anaemia was 16.7%, which could have been reduced by provision of safe blood transfusion. Most of the children (80.2%) presented to the hospital in more than 24 hours after the onset of the illness. Forty seven percent of children received drugs at home and in 96% of the cases it was antimalarial drugs. The antimalarial drug treatment (dose/duration) was adequate in 71%. Children receiving appropriate anti-malaria treatment at home show a tendency towards a lower CFR. The total direct cost per disease episode ranged from USD 13.75 to 27.5. Eighty five percent of the direct cost was due to expenditures in the hospital. Implementation of the management protocol based on the WHO guidelines has required substantial input of resources. Major constraints noted were related to availability of safe blood andfollow-up after discharge. The study provides useful information for improved case management of severe malaria thereby reduce mortality of the under-five children due to severe malaria.
在埃塞俄比亚的一家区级医院,针对五岁以下儿童的重症疟疾开展了一项为期一年的前瞻性医院研究,以确定病死率(CFR)、导致高死亡率的因素、看护者的就医行为、直接成本以及在区级层面实施世界卫生组织治疗指南的可行性。该研究招募了101名年龄在6至59个月之间符合重症疟疾标准的儿童,并按照世界卫生组织的指南进行治疗。重症疟疾最常见的临床表现是极度虚弱和低血糖,患病率分别为28.7%。重症疟疾的总体病死率为11.9%。脑型疟疾是唯一一种病死率高的重症疟疾单独形式(比值比=5.06,95%置信区间1.01-25.1)。严重贫血的医院病死率为16.7%,通过提供安全输血本可降低这一比例。大多数儿童(80.2%)在发病超过24小时后才到医院就诊。47%的儿童在家中接受了药物治疗,其中96%的情况是抗疟药物。71%的抗疟药物治疗(剂量/疗程)是足够的。在家中接受适当抗疟治疗的儿童病死率有降低的趋势。每个疾病发作的总直接成本在13.75美元至27.5美元之间。85%的直接成本是医院支出。基于世界卫生组织指南实施管理方案需要大量资源投入。指出主要的制约因素与安全血液的可获得性和出院后的随访有关。该研究为改善重症疟疾的病例管理提供了有用信息,从而降低五岁以下儿童因重症疟疾导致的死亡率。